Form 4: Celldex Therapeutics SVP Margo Heath-Chiozzi Reports Stock Option Exercises and Share Sales

Margo Heath-Chiozzi, SVP of Regulatory Affairs at Celldex Therapeutics, exercised stock options and sold shares of common stock on May 30, 2024.

Summary

• On May 30, 2024, Margo Heath-Chiozzi, SVP of Regulatory Affairs at Celldex Therapeutics, exercised incentive stock options to acquire 29,068 shares at $2.78, 2,043 shares at $9.0165, and 2,608 shares at $10.38.
• She then sold 38,719 shares of common stock at a weighted average price of $34.07, with individual sales ranging from $33.850 to $34.445 per share.
• Following these transactions, Heath-Chiozzi directly owns 7,094 shares of common stock and holds options to purchase 12,732 shares at $2.78, 6,289 shares at $9.0165, and 81,392 shares at $10.38.

Sentiment

Score: 5

Explanation: This is a routine disclosure of insider transactions. The sentiment is neutral as it simply reflects the execution of stock options and subsequent sale of shares.

Industry Context

Form 4 filings are a routine part of the financial markets, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• Shareholders may interpret insider sales as a sign that the insider believes the stock is fairly valued or overvalued.

Key Dates